Status:
COMPLETED
Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease
Lead Sponsor:
Winthrop University Hospital
Collaborating Sponsors:
Stony Wold-Herbert Fund, Inc.
Conditions:
Chronic Lung Diseases
COPD
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether Written Disclosure Therapy (WDT) is of any benefit to patients with chronic lung diseases who are participating in pulmonary rehabilitation.
Detailed Description
Chronic lung diseases are typically associated with impaired quality of life, stress, and anxiety. Written disclosure therapy (WDT) reduces stress in patients with a variety of chronic illnesses. We s...
Eligibility Criteria
Inclusion
- Diagnosis of COPD or Pulmonary Fibrosis
- First time participants in Pulmonary Rehabilitation program
Exclusion
- Dementia
- Prior significant psychiatric illness
- Inability to complete the questionnaires
- Inability cooperate with spirometry
- Inability or to participate in outpatient follow-up over the six-month
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT00911794
Start Date
January 1 2007
End Date
March 1 2009
Last Update
June 2 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.